Citigroup Earnings Dominated by Deep Discount to Book Value
Citigroup released a better-than-expected second-quarter earnings report Thursday before the markets opened.
All Work
Chris Lange
Why Netflix Is Soaring Even Higher After Earnings
courtesy of NetflixNetflix, Inc. (NASDAQ: NFLX) reported its second quarter financial results after the markets closed Wednesday. The online streaming giant had $0.06 in earnings per share (EPS) on $1.48 billion in revenue compared…
What to Expect From Goldman Sachs Earnings
Goldman Sachs is set to report its second-quarter financial results Thursday morning before the markets open.
What to Expect From Citigroup Earnings
Citigroup is scheduled to report its second-quarter financial results Thursday before the markets open.
UTAC Files for IPO
UTAC Holdings has filed with the U.S. Securities and Exchange Commission (SEC) for its initial public offering (IPO).
Is Celgene Transforming Itself With Mergers and Pacts?
Celgene and Receptos announced Tuesday that they had signed a definitive agreement in which the former will acquire the latter in a deal worth roughly $7.2 billion.
Why Aetna Is Now a Bargain
Argus thinks the sell-off in Aetna stock following the Humana merger announcement on July 3 presents a buying opportunity.
Can Netflix Keep Its Rally Alive With Earnings?
Netflix is scheduled to release its second-quarter financial results on Wednesday after the markets close.
Can Intel Turn Itself Back Around With Earnings?
Intel is scheduled to release its second-quarter earnings report Wednesday after the markets close.
ProNai Therapeutics Sets Price for IPO
ProNai Therapeutics has set the price for its initial public offering (IPO) that values it up to roughly $158 million.
BlackRock Posts Solid Q2 Earnings Beat
BlackRock reported better-than-expected second-quarter financial results Wednesday before the markets opened.
Another Confusing Earnings Report From Yum
courtesy of KFCYum! Brands, Inc. (NYSE: YUM) reported its second-quarter financial results Tuesday after the market closed. The company had $0.69 in earnings per share (EPS) on $3.11 in revenue versus Thomson Reuters consensus…
BioCardia Sets Price For IPO
ThinkstockBioCardia, Inc. filed an amended S-1 form with the Securities and Exchange Commission (SEC) regarding its initial public offering. In this filing the company gave its expected price range as $12 to $14 for about…
Will BofA Discount to Book Value Enhance Earnings?
courtesy of Alex Proimos, via Wikimedia CommonsBank of America Corp. (NYSE: BAC) is scheduled to report its second quarter financial results Wednesday before the markets open. The consensus estimates from Thomson Reuters call for…
Match to Acquire PlentyOfFish
ThinkstockA subsidiary of IAC/InterActiveCorp (NASDAQ: IACI), The Match Group, announced Tuesday that it has entered into a definitive agreement to purchase PlentyOfFish. The total transaction is valued at $575 million. The transaction is expected…
Looking at the Upside in 4 Hotel Stocks
ThinkstockSo far 2015 has not been a good year for most hotel stocks, but this weakness could prove to be a good opportunity. In fact, one key analyst sees these hotel stocks on the…
Nasdaq Lists New SuperDividend ETF
The Global X SuperDividend Alternatives ETF began trading on the Nasdaq on Tuesday July 14.
Is Google Slowing Its Own Growth?
As Google continues to grow, it has to be mindful of how to more efficiently run its massive empire. According to the Wall Street Journal, Google is pursuing this strategy by curbing its hiring.
Why One Ambarella Bull Is Even More Bullish
Canaccord Genuity reiterated a Buy rating on Ambarella and raised its price target, citing drone camera revenue and VisLab acquisition.
Why Biogen Is Now a Buy on Weakness
Merrill Lynch sees Biogen returning to these heightened levels, with its pipeline acting as the primary catalyst.